South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)


No. of Pages: 114    |    Report Code: BMIRE00027546    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market

The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028. 

Introduction of Artificial Intelligence to Provide Opportunities to South & Central America Helicobacter 


Pylori (H. pylori) Non-invasive Testing Market Players 

The advancement in the field of computer technologies has led to the introduction of artificial intelligence technologies, which have been utilized to enhance the diagnosis and predict disease progression and treatment planning. Several studies have shown the capability of artificial intelligence in predicting H. pylori status for diagnosing gastritis. In 2019, Cancer Informatics and Inspirata entered into a technical partnership with DeePathology to grant joint customers the ability to utilize the DeePathology H. pylori decision support system, a screening tool, directly from Dynamyx, a digital pathology solution by Inspirata. The product can enhance reporting accuracy and safely accelerate the H. Pylori diagnostic process. Thus, the emergence of artificial intelligence will offer new opportunities for pharmaceutical companies, which is expected to provide growth opportunities to the helicobacter pylori (H. pylori) non-invasive testing market. 

Market Overview 

The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period. 

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million) 

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million) 
Get more information on this report

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Strategic Insights

Strategic insights for the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-and-central-america-helicobacter-pylori-h-pylori-non-invasive-testing-market-strategic-framework.webp
Get more information on this report

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Report Scope

Report Attribute Details
Market size in 2022 US$ 26.14 Million
Market Size by 2028 US$ 34.64 Million
Global CAGR (2022 - 2028) 4.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Test Type
  • Serology
  • Stool Antigen
  • Urea Breath
By Test Method
  • Laboratory Based
  • Point-of-Care
By End User
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • CerTest Biotec; Coris BioConcept
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Meridian Bioscience Inc.
  • QuidelOrtho Corporation
  • Sekisui Diagnostics
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • Thermo Fisher Scientific Inc.
  • Get more information on this report

    South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Regional Insights

    The geographic scope of the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-and-central-america-helicobacter-pylori-h-pylori-non-invasive-testing-market-geography.webp
    Get more information on this report

    South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation 

    The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country. 
    Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.

    The List of Companies - South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market

    1. Abbott Laboratories
    2. Bio-Rad Laboratories Inc.
    3. CerTest Biotec; Coris BioConcept
    4. Coris BioConcept
    5. DiaSorin S.p.A.
    6. Meridian Bioscience Inc.
    7. QuidelOrtho Corporation
    8. Sekisui Diagnostics
    9. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
    10. Thermo Fisher Scientific Inc.
    Frequently Asked Questions
    How big is the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market?

    The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market is valued at US$ 26.14 Million in 2022, it is projected to reach US$ 34.64 Million by 2028.

    What is the CAGR for South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market by (2022 - 2028)?

    As per our report South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, the market size is valued at US$ 26.14 Million in 2022, projecting it to reach US$ 34.64 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.

    What segments are covered in this report?

    The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report typically cover these key segments-

  • Test Type (Serology, Stool Antigen, Urea Breath)
  • Test Method (Laboratory Based, Point-of-Care)
  • End User (Hospitals, Clinics, Diagnostic Laboratories)
  • What is the historic period, base year, and forecast period taken for South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market?

    The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • CerTest Biotec; Coris BioConcept
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Meridian Bioscience Inc.
  • QuidelOrtho Corporation
  • Sekisui Diagnostics
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • Thermo Fisher Scientific Inc.
  • Who should buy this report?

    The South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market value chain can benefit from the information contained in a comprehensive market report.